| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Wade Berrettini | |
| P2860 | cites work | Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations | Q38154719 |
| Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis | Q38184547 | ||
| The Opioid Epidemic in the United States. | Q38822300 | ||
| Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities | Q39954593 | ||
| Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. | Q40367486 | ||
| Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013. | Q40437669 | ||
| Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins | Q42596030 | ||
| Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities | Q42686475 | ||
| Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation | Q43561649 | ||
| Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis | Q44109189 | ||
| Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. | Q44331377 | ||
| The Surge of Opioid Use, Addiction, and Overdoses: Responsibility and Response of the US Health Care System | Q44344477 | ||
| Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking | Q46152841 | ||
| Amygdala habituation: a reliable fMRI phenotype. | Q48496223 | ||
| Frequency of prescription pain reliever nonmedical use: 2002-2003 and 2009-2010 | Q64129228 | ||
| Deletion of LCE3C_LCE3B is associated with rheumatoid arthritis and systemic lupus erythematosus in the Chinese Han population | Q84235310 | ||
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
| Genome-wide association study of copy number variations (CNVs) with opioid dependence | Q30303052 | ||
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts | Q30316113 | ||
| An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans | Q30543145 | ||
| Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis | Q30912173 | ||
| A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations | Q33715736 | ||
| Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations | Q33767175 | ||
| Neurobiology of addiction: a neurocircuitry analysis | Q34535855 | ||
| Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis | Q34603580 | ||
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1 | Q35901259 | ||
| Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients | Q35968979 | ||
| Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations | Q36431241 | ||
| Temporal dynamics and genetic control of transcription in the human prefrontal cortex | Q36435510 | ||
| Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial | Q36527454 | ||
| Evidence of CNIH3 involvement in opioid dependence. | Q36540800 | ||
| Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update | Q36664176 | ||
| Central amygdala GluA1 facilitates associative learning of opioid reward | Q37013341 | ||
| Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Q37336196 | ||
| Genome-wide association study identifies a potent locus associated with human opioid sensitivity | Q37414547 | ||
| Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways | Q37711041 | ||
| OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis | Q38104745 | ||
| Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. | Q38133047 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P433 | issue | 3 | |
| P921 | main subject | genetics | Q7162 |
| pharmacogenetics | Q1358521 | ||
| opioid-related disorders | Q67085655 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 229-236 | |
| P577 | publication date | 2017-09-01 | |
| P1433 | published in | Dialogues in Clinical Neuroscience | Q24255736 |
| P1476 | title | A brief review of the genetics and pharmacogenetics of opioid use disorders | |
| P478 | volume | 19 |
| Q60920772 | Microglia Express Mu Opioid Receptor: Insights From Transcriptomics and Fluorescent Reporter Mice |
| Q91829800 | OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches |
| Q90575204 | Pharmacogenetics and Psychiatric Care: A Review and Commentary |
| Q90135702 | Pharmacogenomics: What the Doctor Ordered? |
| Q91796599 | The Cholinergic System as a Treatment Target for Opioid Use Disorder |
Search more.